SummaryAngiotensin II (Ang II) is a key proapoptotic factor in fibrotic tissue diseases. However, the mechanism of Ang-II-induced cell death in endothelial cells has not been previously elucidated. Using the neutral comet assay and specific receptor antagonists and agonists, we found that Ang-II-mediated apoptosis in primary pulmonary endothelial cells required the AT2 receptor. Ang II caused cytochrome c release from the mitochondria concurrent with caspase-3 activation and DNA fragmentation, and apoptosis was suppressed by an inhibitor of Bax-protein channel formation, implicating mitochondrial-mediated apoptosis. There was no evidence that the extrinsic apoptotic pathway was involved, because caspase-9, but not caspase-8, was activated by Ang-II treatment. Apoptosis required phosphoprotein phosphatase activation, and inhibition of the SHP-2 phosphatase (encoded by Ptpn11) blocked cell death. Reduced levels of anti-apoptotic Bcl-2-family members can initiate intrinsic apoptosis, and we found that Ang-II treatment lowered cytosolic Bcl-x L protein levels. Because the protein nucleolin has been demonstrated to bind Bcl-x L mRNA and prevent its degradation, we investigated the role of nucleolin in Ang-II-induced loss of Bcl-x L . RNA-immunoprecipitation experiments revealed that Ang II reduced the binding of nucleolin to Bcl-x L mRNA in an AU-rich region implicated in instability of Bcl-x L mRNA. Inhibition of SHP-2 prevented Ang-II-induced degradation of Bcl-x L mRNA. Taken together, our findings suggest that nucleolin is a primary target of Ang-II signaling, and that Ang-II-activated SHP-2 inhibits nucleolin binding to Bcl-x L mRNA, thus affecting the equilibrium between pro-and anti-apoptotic members of the Bcl-2 family.